819 Capital Partners
Overview
819 Capital Partners is a venture capital firm based in Nijmegen, the Netherlands, that invests in early-stage companies in the medical technology sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LipoCoat | Apr 2020 | Series A | Co-investor |
| Neuroplast | Feb 2020 | Series A | Co-investor |
| ATRO Medical | Feb 2026 | Early Funding | Co-investor |
| Lead Pharma | Mar 2026 | Buyout/LBO | Lead |
| Wolk | Apr 2026 | VC Round | Lead |
For institutional investors. Book with your work email.
Key People
Sven Kempers
Partner and co-founder
Frans van den Berg
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 819 Capital Partners based?
819 Capital Partners is headquartered in Nijmegen, Netherlands.
When was 819 Capital Partners founded?
819 Capital Partners was founded in 2021.
How many portfolio companies does 819 Capital Partners have?
819 Capital Partners has 9 portfolio companies in Caplight's dataset.
What are some companies in 819 Capital Partners's portfolio?
Portfolio companies visible on Caplight include LipoCoat, Neuroplast, ATRO Medical, Lead Pharma, Wolk.
What was 819 Capital Partners's most recent investment shown here?
819 Capital Partners's most recent investment in this portfolio sample was in Wolk in 2026.
What sectors does 819 Capital Partners focus on?
819 Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does 819 Capital Partners focus on?
819 Capital Partners typically invests at the Early stage.